शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEKK Shah Hospitals Ltd· Healthcare ServicesHighNeutral
Announced Tue, 27 May, 2025 · 13:07 IST

Financial Result as on 31st March, 2025

Revenue growth above 20%Net loss reportedEBITDA margin compressionResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
—Next day
—
prior close
₹38.80
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.2%—
Hospital peers, median of 21sector-1.1%—
Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
—-0.1—-0.8—
Next day
—+0.2—-1.1—
2d
—+0.6—-1.1—
3d
—+0.9—-1.8—
4d
—+1.0—-1.1—
5d
—+0.7—-1.8—
1w
—+1.8—-1.6—
15d
—+1.7—-1.3—
1m
—+3.1—+1.8—
2m
—+1.7—+7.4—
3m
—-1.0—+8.8—
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 21Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

KK Shah Hospitals reported FY25 revenue from operations of ₹899.86 lakhs, up about 31% from ₹687.85 lakhs in FY24, with total income of ₹955.40 lakhs. However, the company swung to a net loss of ₹32.72 lakhs compared to a profit of ₹60.72 lakhs in the previous year, as total expenses surged to ₹988.04 lakhs (up 48% YoY) driven by higher depreciation (₹101.27 lakhs vs ₹37.91 lakhs) and other expenses. The second half of the year was particularly weak with a ₹70.06 lakh loss against a ₹37.34 lakh profit in H1. The balance sheet shows heavy capital investment, with tangible assets rising over six-fold to ₹776.77 lakhs and capital work-in-progress at ₹650.37 lakhs, pointing to an ongoing expansion. Operating cash flow turned positive at ₹225.49 lakhs versus negative ₹58.22 lakhs last year. The auditor (A Y & Company) issued an unmodified opinion, and the board also appointed a new internal auditor and a 5-year secretarial auditor.

Likely market impact

Despite strong revenue growth, the shift into a loss and sharp rise in costs are negatives for near-term profitability, though the heavy capex suggests the company is building capacity for future growth. Shareholders should watch for revenue ramp-up from the new assets to absorb the higher depreciation burden.